Changjiang Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 1/6
Changjiang Pharmaceutical Group has a total shareholder equity of CN¥737.2M and total debt of CN¥787.8M, which brings its debt-to-equity ratio to 106.9%. Its total assets and total liabilities are CN¥3.1B and CN¥2.4B respectively.
Key information
106.9%
Debt to equity ratio
CN¥787.84m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥6.74m |
| Equity | CN¥737.22m |
| Total liabilities | CN¥2.35b |
| Total assets | CN¥3.09b |
Recent financial health updates
No updates
Recent updates
Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Shares Climb 53% But Its Business Is Yet to Catch Up
Nov 14
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%
Aug 11Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
Jun 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough
Apr 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%
Feb 27Financial Position Analysis
Short Term Liabilities: 300391's short term assets (CN¥1.8B) do not cover its short term liabilities (CN¥1.8B).
Long Term Liabilities: 300391's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥522.5M).
Debt to Equity History and Analysis
Debt Level: 300391's net debt to equity ratio (106%) is considered high.
Reducing Debt: 300391's debt to equity ratio has increased from 16.6% to 106.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 300391 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 300391 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 46.3% each year